Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 3, 2026HRTSS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | +7.6% | +5.2% | +9.5% | +20.2% | — | — | +49.2% |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $57M
- Expense ratio
- 0.99%
- Distribution yield
- 1.2%
- NAV
- $38.76
- Volume
- 1K
- Avg. volume 30D
- 2K
- High today
- $38.74
- Low today
- $38.64
- Previous close
- $38.77
- 52-week high
- $39.03
- 52-week low
- $32.00
- Our risk indicator
- 4/5
HRTS in One Breath
HRTS Among Its Peers
YTDEnd-of-day Nov 4, 2026 · 1 ETFs by YTD
$10,000 in HRTS
5Y$10,000 in HRTS became
$14,925
In the S&P 500 (VOO)
$17,304
Total return, dividends in · Nov 21, 2023 – Nov 3, 2026 · S&P 500 uses VOO
HRTS’s Top Holdings
TodayLLYEli Lilly &12.8%TMO5.0%MRK4.5%RHHBY4.4%KOD3.7%BBIO3.6%RVMD3.5%GILD3.5%UNH3.3%AZN.L3.2%NOVN.SW3.1%DHR3.1%JNJ3.0%ABT3.0%CYTK3.0%NOVO-B.CO3.0%VRTX2.9%ISRG2.4%ABBV2.3%MDT2.2%MCK2.0%SYK25 more
LLYEli Lilly &12.8%TMO5.0%MRK4.5%RHHBY4.4%KOD3.7%BBIO3.6%RVMD3.5%GILD3.5%UNH3.3%AZN.L3.2%NOVN.SW3.1%DHR3.1%35 more
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsOther
Tema HRTS · 47 holdings · tile size = share of the fund · as of Nov 3, 2026
What HRTS Holds
TodayDrug Manufacturers - General44.0%
LLY 12.8 · MRK 4.5 · RHHBY 4.4 · GILD 3.5 · AZN.L 3.2 · NOVN.SW 3.1 · JNJ 3.0
Biotechnology23.3%
KOD 3.7 · BBIO 3.6 · RVMD 3.5 · CYTK 3.0 · VRTX 2.9 · REGN 1.3 · MDGL 1.1
Medical - Devices12.0%
ABT 3.0 · MDT 2.2 · SYK 2.0 · EW 1.4 · DXCM 1.3 · BSX 1.2 · SOON.SW
Medical - Diagnostics & Research9.1%
TMO 5.0 · DHR 3.1 · ILMN 1.1
Medical - Healthcare Plans5.2%
UNH 3.3 · CNC 1.9
Medical - Instruments & Supplies2.4%
ISRG 2.4
Medical - Distribution2.0%
MCK 2.0
Tema HRTS · share of the fund by industry · as of Nov 3, 2026
Eli’s Share of HRTS
Today12.8%
$128 of every $1,000 in HRTS is Eli
Eli held by HRTS
$7.3M
Tema HRTS · each square = $10 of $1,000 · as of Nov 3, 2026
HRTS’s Size vs Its Peers
Today$57.4Mthe largest ETF
AUM · HRTS and the 0 largest peers · Nov 4, 2026
HRTS Fee per $100 vs Peers
TodayExpense ratio · peers · Nov 4, 2026
Inside HRTS
47 holdings · as of Nov 3, 2026HRTS
Tema Heart & Health ETF
TodayDrug Manufacturers - General44.0%LLY12.8%MRK4.5%RHHBY4.4%GILD3.5%AZN.L3.2%NOVN.SW3.1%JNJ3.0%NOVO-B.CO3.0%ABBV2.3%BMYAMGNBiotechnology23.3%KOD3.7%BBIO3.6%RVMD3.5%CYTK3.0%VRTX2.9%REGNMDGLSTOKARWRXENEMBXSRRKGMABVKTXMedical - Devices12.0%ABTMDTSYKEWDXCMBSXSOON.PODDMedical - Diagnostics9.1%TMO5.0%DHR3.1%ILMNMedical - Healthcare Plans5.2%UNH3.3%CNCMedical - Instruments2.4%ISRGMCKTEVACTY
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.77% |
| 2 | TMO | Thermo Fisher Scientific | 4.97% |
| 3 | MRK | Merck & | 4.46% |
| 4 | RHHBY | Roche AG | 4.36% |
| 5 | KOD | Kodiak Sciences | 3.68% |
| 6 | BBIO | Bridgebio Pharma | 3.56% |
| 7 | RVMD | Revolution Medicines | 3.50% |
| 8 | GILD | Gilead Sciences | 3.46% |
| 9 | UNH | Unitedhealth Group | 3.30% |
| 10 | AZN.L | Astrazeneca | 3.21% |
Drug Manufacturers - GeneralBiotechnologyMedical - DevicesMedical - DiagnosticsMedical - Healthcare PlansMedical - InstrumentsMedical - DistributionDrug Manufacturers - SpecialtyOther
Tema HRTS · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 75.3%
How It Compares
HRTS
Tema Heart & Health ETF’s Peers
YTDHRTS has no close peers in our data yet: […]
Similar peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
HRTS vs VOO
YTDHRTS · Tema Heart & Health
+9.5%
VOO · S&P 500
+11.5%
Gap
2.1 pts
Tema HRTS and Vanguard VOO · YTD total return · as of Nov 4, 2026
HRTS vs Its Peer Average
YTDHRTSAvsBPeer average
1D−0.3%[…]
1M+7.6%[…]
3M+5.2%[…]
YTD+9.5%[…]
1Y+20.2%[…]
0–0level
0 peers · each row scaled to its leader
The Details
HRTS
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y16.60%
Deepest drop · 1Y−11.0%
Lowest point · 5Y0.0%
52-week range
$38.64
$32.00−1.0% from the high$39.03
Tema HRTS · past-year price moves · as of Nov 4, 2026
HRTS
Fund Facts
Today2023launched Nov 20
Tracks[…]
Exchange · CUSIPNASDAQ · 87975E883
StructureETF
Leverage1x
Cost on $10,000$99 a year
Go deeper
Tema HRTS · fund facts · as of Nov 4, 2026
HRTS
Payouts by Year
2Y$0.47per share, Dec 2025
Distribution yield1.2%
Paid[…]
Latest ex-date · paidDec 10 · Dec 11, 2025
2 payouts added up$0.94 a share
Tema HRTS · distributions by ex-date · 2024–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗SEC reported portfolio · 2026-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$38.76
Premium / discount[…]
Median spread · 30D[…]
Volume today1K
Average volume · 30D2K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.99%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$99.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |
Issuer contentFrom TemaHear the strategy from the people behind HRTS.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →